Recombinant human thyroid stimulating hormone does not acutely change serum osteoprotegerin and soluble receptor activator of nuclear factor-kappaBeta ligand in patients under evaluation for differentiated thyroid carcinoma.
Giusti, Massimo
Recombinant human thyroid stimulating hormone does not acutely change serum osteoprotegerin and soluble receptor activator of nuclear factor-kappaBeta ligand in patients under evaluation for differentiated thyroid carcinoma. [electronic resource] - Hormones (Athens, Greece) - 304-13 p. digital
Publication Type: Journal Article
1109-3099
10.14310/horm.2002.1111026 doi
Adult
Aged
Aging
Calcium--urine
Creatinine--urine
Female
Humans
Hydroxyproline--urine
Iodine Radioisotopes--therapeutic use
Male
Middle Aged
Osteoporosis--physiopathology
Osteoprotegerin--blood
Postmenopause
Premenopause
RANK Ligand--blood
Recombinant Proteins--administration & dosage
Thyroid Neoplasms--blood
Thyroidectomy
Thyrotropin--administration & dosage
Thyroxine--administration & dosage
Recombinant human thyroid stimulating hormone does not acutely change serum osteoprotegerin and soluble receptor activator of nuclear factor-kappaBeta ligand in patients under evaluation for differentiated thyroid carcinoma. [electronic resource] - Hormones (Athens, Greece) - 304-13 p. digital
Publication Type: Journal Article
1109-3099
10.14310/horm.2002.1111026 doi
Adult
Aged
Aging
Calcium--urine
Creatinine--urine
Female
Humans
Hydroxyproline--urine
Iodine Radioisotopes--therapeutic use
Male
Middle Aged
Osteoporosis--physiopathology
Osteoprotegerin--blood
Postmenopause
Premenopause
RANK Ligand--blood
Recombinant Proteins--administration & dosage
Thyroid Neoplasms--blood
Thyroidectomy
Thyrotropin--administration & dosage
Thyroxine--administration & dosage